Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
Studies on the neonatal Fc receptor (FcRn) have revealed a multitude of important functions in mammals, including protection of IgG and serum albumin (SA) from lysosomal degradation. The pharmacokinetic behavior of therapeutic antibodies, IgG-Fc- and SA-containing drugs is therefore influenced by th...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e4060617ee8a4ebb811b810ebd70a15b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e4060617ee8a4ebb811b810ebd70a15b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e4060617ee8a4ebb811b810ebd70a15b2021-11-18T08:46:07ZRobust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.1932-620310.1371/journal.pone.0081350https://doaj.org/article/e4060617ee8a4ebb811b810ebd70a15b2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260574/?tool=EBIhttps://doaj.org/toc/1932-6203Studies on the neonatal Fc receptor (FcRn) have revealed a multitude of important functions in mammals, including protection of IgG and serum albumin (SA) from lysosomal degradation. The pharmacokinetic behavior of therapeutic antibodies, IgG-Fc- and SA-containing drugs is therefore influenced by their interaction with FcRn. Pre-clinical development of such drugs is facilitated if their interaction with FcRn can be studied in vitro. For this reason we have developed a robust system for production of the soluble extracellular domain of human FcRn as well as the full-length receptor as fusion to green fluorescent protein, taking advantage of a lentivirus-based gene delivery system where stable over-expressing cells are easily and rapidly generated. Production of the extracellular domain in multiple-layered culture flasks, followed by affinity purification using immobilized IgG, resulted in capture of milligram amounts of soluble receptor per liter cell culture with retained IgG binding. The receptor was further characterized by SDS-PAGE, western blotting, circular dichroism spectroscopy, ELISA, surface plasmon resonance and a temperature stability assay showing a functional and stable protein of high purity. The full-length receptor was found to be successfully over-expressed in a membrane-bound form with retained pH-dependent IgG- and SA-binding.Johan SeijsingMalin LindborgJohn LöfblomMathias UhlénTorbjörn GräslundPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e81350 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Johan Seijsing Malin Lindborg John Löfblom Mathias Uhlén Torbjörn Gräslund Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP. |
description |
Studies on the neonatal Fc receptor (FcRn) have revealed a multitude of important functions in mammals, including protection of IgG and serum albumin (SA) from lysosomal degradation. The pharmacokinetic behavior of therapeutic antibodies, IgG-Fc- and SA-containing drugs is therefore influenced by their interaction with FcRn. Pre-clinical development of such drugs is facilitated if their interaction with FcRn can be studied in vitro. For this reason we have developed a robust system for production of the soluble extracellular domain of human FcRn as well as the full-length receptor as fusion to green fluorescent protein, taking advantage of a lentivirus-based gene delivery system where stable over-expressing cells are easily and rapidly generated. Production of the extracellular domain in multiple-layered culture flasks, followed by affinity purification using immobilized IgG, resulted in capture of milligram amounts of soluble receptor per liter cell culture with retained IgG binding. The receptor was further characterized by SDS-PAGE, western blotting, circular dichroism spectroscopy, ELISA, surface plasmon resonance and a temperature stability assay showing a functional and stable protein of high purity. The full-length receptor was found to be successfully over-expressed in a membrane-bound form with retained pH-dependent IgG- and SA-binding. |
format |
article |
author |
Johan Seijsing Malin Lindborg John Löfblom Mathias Uhlén Torbjörn Gräslund |
author_facet |
Johan Seijsing Malin Lindborg John Löfblom Mathias Uhlén Torbjörn Gräslund |
author_sort |
Johan Seijsing |
title |
Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP. |
title_short |
Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP. |
title_full |
Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP. |
title_fullStr |
Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP. |
title_full_unstemmed |
Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP. |
title_sort |
robust expression of the human neonatal fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with egfp. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/e4060617ee8a4ebb811b810ebd70a15b |
work_keys_str_mv |
AT johanseijsing robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp AT malinlindborg robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp AT johnlofblom robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp AT mathiasuhlen robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp AT torbjorngraslund robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp |
_version_ |
1718421356027052032 |